Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
- PMID: 22514849
- Bookshelf ID: NBK64164
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
Excerpt
This TIP, Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs, incorporates the many changes in medication-assisted treatment for opioid addiction (MAT) that have occurred over the most active decade of change since the inception of this treatment modality approximately 40 years ago. The TIP describes the nature and dimensions of opioid use disorders and their treatment in the United States, including basic principles of MAT and historical and regulatory developments. It presents consensus panel recommendations and evidence-based best practices for treatment of opioid addiction in opioid treatment programs (OTPs). It also examines related medical, psychiatric, sociological, and substance use disorders and their treatment as part of a comprehensive maintenance treatment program. The TIP includes a discussion of the ethical considerations that arise in most OTPs, and it provides a useful summary of areas for emphasis in successfully administering MAT in OTPs.
Sections
- Acknowledgments
- What Is a TIP?
- Consensus Panel
- Editorial Advisory Board
- Consensus Panelists
- KAP Expert Panel and Federal Government Participants
- Foreword
- Executive Summary
- Chapter 1. Introduction
- Chapter 2. History of Medication-Assisted Treatment for Opioid Addiction
- Chapter 3. Pharmacology of Medications Used To Treat Opioid Addiction
- Chapter 4. Initial Screening, Admission Procedures, and Assessment Techniques
- Chapter 5. Clinical Pharmacotherapy
- Chapter 6. Patient-Treatment Matching: Types of Services and Levels of Care
- Chapter 7. Phases of Treatment
- Chapter 8. Approaches to Providing Comprehensive Care and Maximizing Patient Retention
- Chapter 9. Drug Testing as a Tool
- Chapter 10. Associated Medical Problems in Patients Who Are Opioid Addicted
- Chapter 11. Treatment of Multiple Substance Use
- Chapter 12. Treatment of Co-Occurring Disorders
- Chapter 13. Medication-Assisted Treatment for Opioid Addiction During Pregnancy
- Chapter 14. Administrative Considerations
- Appendix A: Bibliography
- Appendix B: Abbreviations and Acronyms
- Appendix C: Glossary
- Appendix D: Ethical Considerations in MAT
- Appendix E: Resource Panel
- Appendix F: Field Reviewers
Similar articles
-
Characterizing variability in state-level regulations governing opioid treatment programs.J Subst Abuse Treat. 2020 Aug;115:108008. doi: 10.1016/j.jsat.2020.108008. Epub 2020 Apr 24. J Subst Abuse Treat. 2020. PMID: 32600617
-
Trends in the Use of Methadone and Buprenorphine at Substance Abuse Treatment Facilities: 2003 to 2011.2013 Apr 23. In: The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013–. 2013 Apr 23. In: The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013–. PMID: 27606405 Free Books & Documents. Review.
-
Medication-assisted treatment for opioid use disorders in correctional settings: an ethics review.Int J Drug Policy. 2014 Nov;25(6):1041-6. doi: 10.1016/j.drugpo.2014.08.015. Epub 2014 Aug 30. Int J Drug Policy. 2014. PMID: 25249444
-
Improving public health through access to and utilization of medication assisted treatment.Int J Environ Res Public Health. 2011 Oct;8(10):4102-17. doi: 10.3390/ijerph8104102. Epub 2011 Oct 24. Int J Environ Res Public Health. 2011. PMID: 22073031 Free PMC article. Review.
-
Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.J Addict Med. 2011 Dec;5(4):254-63. doi: 10.1097/ADM.0b013e3182312983. J Addict Med. 2011. PMID: 22042215
Publication types
Grant support
LinkOut - more resources
Full Text Sources